NeuroDigm's Model Reveals the Reversal of Chronic Pain
2/4/2008 9:22:03 AM
FT. WORTH, Texas--(BUSINESS WIRE)--Mary Hannaman MD, president of NeuroDigm Co. in Fort Worth, Texas has confirmed that a recombinant human erythropoietin, epoetin alfa, can reverse neural changes that cause chronic pain behavior. Using their Biogenic Model of Chronic Pain™, epoetin alpha was applied once locally in micro doses to the affected nerves resulting in the reversal of pain behaviors permanently.
comments powered by